We are Sorry, This Page doesn't Exist
Pfizer sales miss as breast cancer drug disappoints
(Reuters) - Leading U.S. drugmaker Pfizer Inc racked up its biggest miss on sales in a year in the first quarter, hurt by lower-than-expected sales of blockbuster breast cancer drug Ibrance and arthritis drug Xeljanz......»»
Pfizer drug Xeljanz receives marketing authorization in EU
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pfizer, Eli Lilly say experimental arthritis drug tanezumab hits FDA snag
Pfizer Inc. and Eli Lilly and Co. said Thursday that a joint advisory committee of the U.S. Food and Drug Administration has vote.....»»
Europe"s drug regulator says there is an extra dose in BioNTech/Pfizer"s COVID-19 vaccine vials
The European Medicines Agency said Friday that the product information for BioNTech SE and Pfizer Inc.'s COVID-19 .....»»
Pfizer, BioNTech recieve marketing authorization for Covid vaccine in Europe
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
The Wall Street Journal: FDA requires box warnings for Pfizer drug Xeljanz
The U.S. Food and Drug Administration is requiring that health warnings be added to Pfizer Inc.’s drug Xeljanz, advising patients they could experience a higher risk of blood clots or death with a specific dose......»»
Pfizer had clues its drug could prevent Alzheimer’s. It didn’t report the findings.
Researchers say Pfizer should have published its analysis on the blockbuster rheumatoid arthritis therapy Enbrel. Pfizer says its decision was based on science......»»
Pfizer had clues its drug could prevent Alzheimer"s. What happened?
The company’s rheumatoid arthritis drug appeared to reduce the risk of getting Alzheimer’s disease by 64 percent. The Washington Post’s Chris Rowland explains why Pfizer did not pursue it......»»
Puma Biotech Out-Licenses Nerlynx Rights in Europe, Stock Down
Puma Biotech (PBYI) out-licenses development and marketing rights to its breast cancer drug Nerlynx to Pierre Fa.....»»
Pfizer"s Arthritis Drug Gets FDA Nod for Ulcerative Colitis
The FDA approve.....»»
Pfizer receives EU marketing authorization for XELJANZ
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Benzinga"s Biotech Pulse: Pfizer"s Xeljanz Gets EU Nod, NewLink Losses Narrow, Neuralstem Commences Stroke Drug Trial
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Pe.....»»
Globant Acquires Europe"s Digital Marketing Consulting Firm HABITANT For Undisclosed Sum
read more.....»»
Pfizer-BioNTech COVID-19 Vaccine Gets FDA Emergency Approval For Age Group 12-15
The U.S. Food and Drug Administration on Monday approved the emergency use of Pfizer Inc. (NYSE: PFE) and BioNTech SE’s (NASDAQ: BNTX) COVID-19 vaccine in adolescents aged between 12 to 15 years. read more.....»»
FDA authorizes emergency use of Pfizer, BioNTech COVID vaccine to kids 12-15
The U.S. Food and Drug Administration late Monday authorized the emergency use of Pfizer Inc. and BioNTech SE COVID-19 vacccine for children between the age.....»»
: Four COVID-19 vaccines are being tested in children and teens. Here’s when different age groups could become eligible for shots.
The Food and Drug Administration is expected to grant emergency authorization to Pfizer's COVID-19 vaccine for 12- to 15-year-olds within the week. If that occurs, it will be the first shot authorized for this group of younger teens......»»
: Four COVID-19 vaccines are being tested in children and teens. Here’s when to expect a shot for different age groups
The Food and Drug Administration is expected to grant emergency authorization to Pfizer's COVID-19 vaccine for 12 to 15-year-olds within the week. If that occurs, it will be the first shot authorized for this group of teens......»»
Europe"s Vaccine Rollout Relies Heavily On Pfizer/BioNTech
Europe's Vaccine Rollout Relies Heavily On Pfizer/BioNTech As Europe’s vaccine rollout is picking up pace, Statista's Felix Richter reports that the European Commissi.....»»
Pfizer: Anticipated Growth at a Fair Value
The drug giant beat earnings expectations and raised guidance following strong Covid-related upsideRelated Stocks: PFE, BNTX,.....»»
Pfizer beats earnings expectations and lifts guidance, as COVID-19 revenue outlook increases 73%
Shares of Pfizer Inc. jumped 1.6% toward a near five-month high in premarket trading Tuesday, after the drug giant beat earnings expectations and raised its full-year outlook, as revenue .....»»